Women-focused psilocybin study for depression
A New Clinical Trial in South Africa Aims to Study the Effect of Psilocybin on
June 6, 2022
A New Clinical Trial in South Africa Aims to Study the Effect of Psilocybin on
Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic
Psyence Group Corporate Update Highlights: Partnership with CRO Clerkenwell Health to design and deliver Psyence’s
Braxia Scientific Presents Positive Preliminary Findings from Phase II Randomized, Multi-Dose Clinical Trial of Psilocybin-Assisted
CaaMTech Collaboration Proves Diversity in Magic Mushroom Chemistry A new paper published by The Leibniz
Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Methods of Administering Psilocybin and Psilocin Patent
Why this startup is encouraging employees to microdose psychedelics at work Shane Health, CEO of
Cybin Submits IND Application to FDA for its Phase 1/2a First-in-Human Trial of CYB003 for
Silo Wellness To Acquire Canadian Dyscovry Science, Producer Of Psilocybin For IBS Treatment Shrooms are
Red Light Holland and Superstar Wiz Khalifa to Launch Naturally Occurring Psilocybin and Mushrooms Wellness
Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc. Halucenex to receive recently
Vancouver Island Craft Cannabis and Psilocybin Farmers Roundtable in Duncan June 16 May 25, 2022
Open for Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation
Ceruvia Lifesciences Submits FDA Investigational New Drug Application for Psilocybin Obsessive-Compulsive Disorder Program Ceruvia Lifesciences
Red Light Holland CCO Russell Peters Completes Psilocybin Truffles Journey in Amsterdam and Will Live
Nirvana Life Sciences Announces Partner Symeres Can Produce High Volume Controlled Substances Vancouver, British Columbia–(Newsfile Corp.
COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting
Braxia Scientific Receives Health Canada Special Access Program Approval to Provide Psilocybin-Assisted Therapy for Depression
CB Therapeutics granted a new patent that will help further provide eco-conscious avenues for psychedelic
Silo Pharma Announces Successful Dosing of Patients Suffering from Parkinson’s Disease in Psilocybin Study Study
UK Member of Parliament Crispin Blunt to Inaugurate Psilocybin Cultivation Facility at Optimi Health Grand
Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics Optimi Health (OPTI) acquired
Albert Labs Granted Health Canada Licence Albert Labs has been issued a Health Canada License
Numinus Wellness Receives Health Canada Special Access Program Applicant Approval to Provide Psychedelic-assisted Therapy Treatment